Prophylactic treatment of intraocular pressure elevations after neodymium: YAG laser posterior capsulotomies and extracapsular cataract extractions with levobunolol

• Published in: Ophthalmology (Rochester, Minn.) Vol. 95; no. 6; p. 713
• Main Authors: Silverstone, D E, Novack, G D, Kelley, E P, Chen, K S
• Format: Journal Article
• Language: English
• Published: United States 01.06.1988
• Subjects: Cataract Extraction - adverse effects; Humans; Intraocular Pressure - drug effects; Laser Therapy - adverse effects; Lens Capsule, Crystalline - surgery; Lens, Crystalline - surgery; Levobunolol - therapeutic use; Postoperative Complications - prevention & control; Postoperative Period
• DOI: 10.1016/S0161-6420(88)33124-6
• ISSN: 0161-6420

The prophylactic effect of topical 0.5% levobunolol on intraocular pressure (IOP) elevations after neodymium:YAG (Nd:YAG) laser posterior capsulotomies and extracapsular cataract extractions (ECCEs) was investigated in two separate, double-masked, placebo-controlled studies. In study 1, 42 patients received either levobunolol or vehicle 1 hour before a unilateral Nd:YAG laser posterior capsulotomy. Elevated IOP (greater than or equal to 10 mmHg) occurred in up to 38% of those in the vehicle group and none in the levobunolol group. Mean IOP increased up to 6 mmHg in the vehicle group, whereas it decreased up to 3 mmHg in the levobunolol group. In study 2, 41 patients received either levobunolol or vehicle immediately after a unilateral ECCE involving the use of a viscoelastic preparation and the implantation of a posterior chamber intraocular lens (PC IOL). The incidence of IOP elevations (greater than or equal to 10 mmHg) was up to 40% in the vehicle group and 19% in the levobunolol group. Mean IOP increased up to 9 mmHg in the vehicle group and up to 2 mmHg in the levobunolol group. Thus, marked elevations in IOP after posterior capsulotomies or ECCEs may be minimized by prophylactic treatment with levobunolol.